Heart Failure Secondary to Chagas Disease: an Emerging Problem in Non-endemic Areas (Q38997192)

8 September 2017

1 reference

title

Heart Failure Secondary to Chagas Disease: an Emerging Problem in Non-endemic Areas (English)

1 reference

8 September 2017

0 references

Mahmoud Traina

1

1 reference

8 September 2017

Sheba Meymandi

series ordinal

2

1 reference

8 September 2017

Jason S Bradfield

series ordinal

3

1 reference

8 September 2017

2 November 2016

1 reference

Current heart failure reports

8 September 2017

1 reference

8 September 2017

13

1 reference

8 September 2017

295-301

1 reference

8 September 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11897-016-0305-9

8 September 2017

0 references

cites work

Trypanosoma cruzi and Chagas' Disease in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chagas disease risk in Texas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Mother-to-child transmission of Chagas' disease in North America: why don't we do more?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Neglected infections of poverty in the United States of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Autochthonous transmission of Trypanosoma cruzi, Louisiana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Seroprevalence ofTrypanosoma cruziinfection in at-risk blood donors in Catalonia (Spain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chagas disease in Spain: need for further public health measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Epidemiology of Chagas disease in non-endemic countries: the role of international migration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Epidemiology of Chagas disease in Europe: many calculations, little knowledge

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chagas disease in Spain, the United States and other non-endemic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: Immigration and Chagas disease in Barcelona (Spain)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Addressing the neglect: Chagas disease in London, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chagas disease in Australia and New Zealand: risks and needs for public health interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chagas disease in Latin American immigrants with dilated cardiomyopathy in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Prevalence and Impact of Chagas Disease Among Latin American Immigrants With Nonischemic Cardiomyopathy in Los Angeles, California.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chagas Cardiomyopathy: Usefulness of EKG and Echocardiogram in a Non-Endemic Country.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Physician awareness of Chagas disease, USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

The healthy donor effect: a matter of selection bias and confounding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Chagas disease awareness among Latin American immigrants living in Los Angeles, California

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Knowledge and experiences of Chagas disease in Bolivian women living in Spain: a qualitative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Barriers to Testing and Treatment for Chagas Disease among Latino Immigrants in Georgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Randomized trial of posaconazole and benznidazole for chronic Chagas' disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Tolerance and safety of nifurtimox in patients with chronic chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Tolerance of benznidazole in a United States Chagas Disease clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Global economic burden of Chagas disease: a computational simulation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Value of cardiac MRI for evaluation of chronic Chagas disease cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the [...]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Radiofrequency catheter ablation of ventricular tachycardia guided by nonsurgical epicardial mapping in chronic Chagasic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Cardiac sympathetic denervation for intractable ventricular arrhythmias in Chagas disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

6-Month Outcomes in Patients With Implantable Cardioverter-Defibrillators Undergoing Renal Sympathetic Denervation for the Treatment of Refractory Ventricular Arrhythmias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Heart transplantation for Chagas cardiomyopathy in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Health policies to control Chagas disease transmission in European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

An Estimate of the Burden of Chagas Disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

A New Technique to Perform Epicardial Mapping in the Electrophysiology Laboratory

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

21 January 2018

12 December 2020

Congenital Transmission of Chagas Disease in Latin American Immigrants in Switzerland

1 reference

https://api.crossref.org/works/10.1007%2FS11897-016-0305-9

Sudden death in Chagas' disease

21 January 2018

1 reference

12 December 2020

Congenital transmission of Chagas disease in Latin American immigrants in Switzerland

1 reference

12 December 2020

[Prevalence of Trypanosoma cruzi infection and vertical transmission in Latin-American pregnant women in a health area of Biscay]

1 reference

12 December 2020

Identifying Chagas disease in Australia: an emerging challenge for general practitioners

1 reference

12 December 2020

The paradox of survival results after heart transplantation for cardiomyopathy caused by Trypanosoma cruzi. First Guidelines Group for Heart Transplantation of the Brazilian Society of Cardiology

1 reference

12 December 2020

Chagas disease and transfusion medicine: a perspective from non-endemic countries

1 reference

12 December 2020

Chagas disease in European countries: the challenge of a surveillance system.

1 reference

12 December 2020

Congenital transmission of Chagas disease - Virginia, 2010.

1 reference

12 December 2020

Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening

1 reference

12 December 2020

Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia.

1 reference

12 December 2020

American trypanosomiasis (Chagas' disease) in Central American immigrants

1 reference

12 December 2020

Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial

1 reference

12 December 2020

10.1007/S11897-016-0305-9

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

0 references

1 reference